ULURU INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2023-04-30: Study NCT05496296; Company role Lead sponsor; Phase Not applicable; Status Recruiting.
- 2022-05-26: Study NCT05424354; Company role Lead sponsor; Phase Phase 4; Status Recruiting.
- 2021-08-16: Study NCT05046158; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2008-05: Study NCT01062204; Company role Lead sponsor; Phase Not applicable; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2023-04-30 | NCT05496296 Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries | Lead sponsor | Not applicable | Recruiting | Pressure Ulcers Stage II; Pressure Ulcers Stage III; Pressure Ulcer, Stage IV | 300 | 2026-12 |
| 2022-05-26 | NCT05424354 Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing | Lead sponsor | Phase 4 | Recruiting | Wounds and Injuries | 60 | 2026-09-30 |
| 2021-08-16 | NCT05046158 Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care | Lead sponsor | Not applicable | Completed | Diabetic Foot Ulcer | 135 | 2025-11-06 |
| 2008-05 | NCT01062204 Altrazeal™ Versus Aquacel® Ag for Partial Thickness Skin Donor Sites | Lead sponsor | Not applicable | Completed | Partial-thickness Skin Donor Sites | 40 | 2009-12 |
| 2007-05 | NCT01062191 Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl | Lead sponsor | Not applicable | Terminated | Burn | 3 | 2008-10 |